PROCEEDINGS VOLUME 1616
INTERNATIONAL CONFERENCE ON PHOTODYNAMIC THERAPY AND LASER MEDICINE | 15-17 OCTOBER 1991
International Conference on Photodynamic Therapy and Laser Medicine
INTERNATIONAL CONFERENCE ON PHOTODYNAMIC THERAPY AND LASER MEDICINE
15-17 October 1991
Beijing, China
Plenary Lectures
Proc. SPIE 1616, Laser medicine in China, 0000 (5 March 1993); doi: 10.1117/12.142540
Proc. SPIE 1616, Photodynamic research at Baylor University Medical Center Dallas, Texas, 0000 (5 March 1993); doi: 10.1117/12.136983
Proc. SPIE 1616, Current applications of lasers in heart disease, 0000 (5 March 1993); doi: 10.1117/12.136994
Proc. SPIE 1616, Photodynamic therapy in China, 0000 (5 March 1993); doi: 10.1117/12.137005
Proc. SPIE 1616, New trends in urological laser research and applications, 0000 (5 March 1993); doi: 10.1117/12.137016
Proc. SPIE 1616, Trial of photodynamic therapy for the treatment of tumors of the skin, head, and neck, and the results of an experimental study to determine the interrelationships between the tissue effects of ioni, 0000 (5 March 1993); doi: 10.1117/12.137027
Proc. SPIE 1616, Combined photodynamic therapy using Photofrin and radiotherapy versus radiotherapy alone in patients with inoperable obstructive nonsmall-cell bronchogenic carcinoma, 0000 (5 March 1993); doi: 10.1117/12.137038
Proc. SPIE 1616, Lasers around the world, 0000 (5 March 1993); doi: 10.1117/12.137049
Proc. SPIE 1616, Dosimetry for photodynamic therapy of malignant tumors, 0000 (5 March 1993); doi: 10.1117/12.137060
Photodynamic Therapy: Clinical
Proc. SPIE 1616, Photodynamic therapy in patients with recurrent gynecological carcinomas, 0000 (5 March 1993); doi: 10.1117/12.136945
Proc. SPIE 1616, Three-year experience in the application of PDT in the treatment of lung cancer, 0000 (5 March 1993); doi: 10.1117/12.136956
Photodynamic Therapy: Basic
Proc. SPIE 1616, Hematoporphyrin-derivative photodynamic in-vitro sensitivity testing for brain tumors, 0000 (5 March 1993); doi: 10.1117/12.136967
Proc. SPIE 1616, Effect of photodynamic therapy on mouse platelets, 0000 (5 March 1993); doi: 10.1117/12.136976
Proc. SPIE 1616, Can PDT be potentiated by immunotherapy?, 0000 (5 March 1993); doi: 10.1117/12.136977
Proc. SPIE 1616, Study of biological effects of sulfonated chloroaluminum phthalocyanine in a transplantable mouse tumor (S180), 0000 (5 March 1993); doi: 10.1117/12.136978
Proc. SPIE 1616, Detection of oral squamous-cell cancer and precancerous lesions by fluorescence imaging in a hamster cheek-pouch model, 0000 (5 March 1993); doi: 10.1117/12.136979
Proc. SPIE 1616, Fundamental and clinical studies of endoscopic Nd:YAG laser balloon irradiation for early gastric cancer, 0000 (5 March 1993); doi: 10.1117/12.136980
Proc. SPIE 1616, Nd:YAG laser therapy in bronchogenic tumors, 0000 (5 March 1993); doi: 10.1117/12.136981
Photodynamic Therapy: Clinical
Proc. SPIE 1616, Photodynamic therapy with Photofrin II by bronchial artery infusion, 0000 (5 March 1993); doi: 10.1117/12.136982
Proc. SPIE 1616, Integral photodynamic therapy of superficial bladder tumors with mainly carcinoma in situ, 0000 (5 March 1993); doi: 10.1117/12.136984
Photodynamic Therapy: Basic
Proc. SPIE 1616, Enhancement of porphyrin tumor accumulation by inhibition of porphyrin liver pathway, 0000 (5 March 1993); doi: 10.1117/12.136985
Proc. SPIE 1616, Characterization of an oral cancer nude mouse model and PDT of these tumors alone as well as in combination with surgical treatment, 0000 (5 March 1993); doi: 10.1117/12.136986
Proc. SPIE 1616, Antitumor therapeutic efficacy of photoactivated phthalocyanines ZnS4PC and AlS2PC in tumor-bearing mice, 0000 (5 March 1993); doi: 10.1117/12.136987
Proc. SPIE 1616, Comparative evaluation of photodynamic activity of several HpD and different samples of sulphonated aluminum phthalocyanine, 0000 (5 March 1993); doi: 10.1117/12.136988
Photodynamic Therapy: Clinical
Proc. SPIE 1616, Treating esophagus-cardiac carcinoma by YAG laser gasifying with irradiating of hemoporphyrin derivative laser: additional analyses of 110 cases, 0000 (5 March 1993); doi: 10.1117/12.136989
Photodynamic Therapy: Basic
Proc. SPIE 1616, Toxicity, pharmacokinetics, and photodynamic properties of chlorin e6, 0000 (5 March 1993); doi: 10.1117/12.136990
Photodynamic Therapy: Clinical
Proc. SPIE 1616, Observation of effects of glass-type gold vapor pulsed laser on 36 cases of malignant tumors, 0000 (5 March 1993); doi: 10.1117/12.136991
Proc. SPIE 1616, Application of 99mTc-labeled hematoporphyrin-derivative in the radio imaging diagnosis of bladder tumors, 0000 (5 March 1993); doi: 10.1117/12.136992
Proc. SPIE 1616, New method for clinical detection of cancer by rapidly analyzing the argon-laser-induced autofluorescence spectra, 0000 (5 March 1993); doi: 10.1117/12.136993
Proc. SPIE 1616, Photodynamic therapy with gold vapor laser in the treatment of bladder cancer, 0000 (5 March 1993); doi: 10.1117/12.136995
Proc. SPIE 1616, Adjuvant photodynamic therapy in surgical management of cerebral tumors, 0000 (5 March 1993); doi: 10.1117/12.136996
Proc. SPIE 1616, Observations of the incidence of metastasis following laser hyperthermia in combination with chemotherapy, PDT, and excision, 0000 (5 March 1993); doi: 10.1117/12.136997
Proc. SPIE 1616, Interstitial photodynamic therapy for cancers of cavum oris, skin, and cervix, 0000 (5 March 1993); doi: 10.1117/12.136998
Proc. SPIE 1616, Endoscopic photodynamic therapy with hematoporphyrin derivative in the treatment of malignant tumors: report of 120 cases, 0000 (5 March 1993); doi: 10.1117/12.136999
Proc. SPIE 1616, PDT for malignant tumors: a clinical analysis of 152 cases, 0000 (5 March 1993); doi: 10.1117/12.137000
Proc. SPIE 1616, Photodynamic therapy of recurrent cerebral glioma, 0000 (5 March 1993); doi: 10.1117/12.137001
Proc. SPIE 1616, Photodynamic combination therapy vs. simple ND:YAG laser for the treatment of cancer of the urinary bladder, 0000 (5 March 1993); doi: 10.1117/12.137002
Proc. SPIE 1616, Study of the clinical application of PDT to the treatment of alimentary tract cancer and precancerous gastric diseases, 0000 (5 March 1993); doi: 10.1117/12.137003
Proc. SPIE 1616, Application of laser and PDT to treatment of recurrent cancer in the paranasal sinuses, 0000 (5 March 1993); doi: 10.1117/12.137004
Proc. SPIE 1616, Photodynamic treatment of bladder cancer: report of 117 cases, 0000 (5 March 1993); doi: 10.1117/12.137006
Proc. SPIE 1616, Hematoporphyrin derivatives high-power interstitial irradiation of argon laser photodynamic therapy for superficial transitional cell bladder tumor, 0000 (5 March 1993); doi: 10.1117/12.137007
Proc. SPIE 1616, Curative effect of photodynamic therapy of pulse laser on cancer detected by computer, 0000 (5 March 1993); doi: 10.1117/12.137008
Proc. SPIE 1616, Study of photodynamic therapy in skin cancers and precancerous lesions, 0000 (5 March 1993); doi: 10.1117/12.137009
Proc. SPIE 1616, Photodynamic therapy in the treatment and diagnosis of cancers: a sixty-case report, 0000 (5 March 1993); doi: 10.1117/12.137010
Proc. SPIE 1616, Diagnosis and treatment of 110 cases of malignant tumors with pulsed-laser photodynamic therapy, 0000 (5 March 1993); doi: 10.1117/12.137011
Proc. SPIE 1616, Radiosensitization of hematoporphyrin derivative: clinical trial on 69 patients, 0000 (5 March 1993); doi: 10.1117/12.137012
Proc. SPIE 1616, Photodynamic therapy of advanced malignant tumors, 0000 (5 March 1993); doi: 10.1117/12.137013
Photodynamic Therapy: Basic
Proc. SPIE 1616, Anti-early pregnancy by PDT, 0000 (5 March 1993); doi: 10.1117/12.137014
Proc. SPIE 1616, Photodynamic effect of copper-vapor pumped-dye laser, He-Ne laser, and noncoherent red light to the liver in normal mice, 0000 (5 March 1993); doi: 10.1117/12.137015
Proc. SPIE 1616, Design of the optical phantom of tissue for photodynamic therapy research, 0000 (5 March 1993); doi: 10.1117/12.137017
Proc. SPIE 1616, Preventive effect of antihistaminics on mouse skin photosensitization with hematoporphyrin derivative, 0000 (5 March 1993); doi: 10.1117/12.137018
Proc. SPIE 1616, Effect of ascorbate on photosensitization of hepatoma cells by hematoporphyrin derivative, 0000 (5 March 1993); doi: 10.1117/12.137019
Proc. SPIE 1616, Mechanism of photodynamic inactivation of hepatocarcinoma cells with sulfonated aluminum phthalocyanine, 0000 (5 March 1993); doi: 10.1117/12.137020
Proc. SPIE 1616, Selective protection of normal hepatocytes by indocyanine green in photodynamic therapy for the hepatoma of rat, 0000 (5 March 1993); doi: 10.1117/12.137021
Proc. SPIE 1616, Immunophotosensitizer: the preparation and antitumor properties of monoclonal antibody-hematoporphyrin conjugate, 0000 (5 March 1993); doi: 10.1117/12.137022
Proc. SPIE 1616, Photodynamic effects of Can-Sha photosensitizer on transplanted tumors in mice, 0000 (5 March 1993); doi: 10.1117/12.137023
Proc. SPIE 1616, New target for laser-hypocrellin A photosensitization: cell membrane DNA, 0000 (5 March 1993); doi: 10.1117/12.137024
Proc. SPIE 1616, Study on energy density of gold-vapor laser and necrosis depth of mouse malignant tumor (S180), 0000 (5 March 1993); doi: 10.1117/12.137025